Keyphrases
Anti-vascular Endothelial Growth Factor (anti-VEGF)
100%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
100%
Intravitreal anti-VEGF
100%
Diabetic Retinopathy Treatment
100%
Diabetic Retinopathy
50%
Diabetic Macular Edema
37%
Panretinal Photocoagulation
37%
Anti-VEGF Therapy
37%
Pars Plana Vitrectomy
25%
Vitreous Hemorrhage
25%
Diabetic Retinopathy Grading
25%
Clinical Trials
12%
Conflicting Results
12%
Visual Acuity
12%
Individualized Approach
12%
PubMed
12%
English Language
12%
Working Population
12%
Standard of Care
12%
Imaging Modalities
12%
2-step
12%
Causes of Blindness
12%
Optical Coherence Tomography Angiography (OCT-A)
12%
Comprehensive Literature Review
12%
Pivotal Trial
12%
Loss-to-follow-up
12%
Proliferative Diabetic Retinopathy
12%
Aflibercept
12%
Ranibizumab
12%
Retinal Thickness
12%
Protocol S
12%
Tractional Retinal Detachment
12%
Background Diabetic Retinopathy
12%
Color Fundus Photography
12%
Vascular Endothelial Growth
12%
Antivascular Therapy
12%
Ultra-widefield Fluorescein Angiography
12%
Retinal Nonperfusion
12%
Medicine and Dentistry
Vasculotropin
100%
Diabetic Retinopathy
100%
Diabetic Macular Edema
23%
Laser Coagulation
23%
Pars Plana Vitrectomy
15%
Vitreous Hemorrhage
15%
Recurrent Disease
7%
Clinical Trial
7%
English (Language)
7%
Visual Acuity
7%
Retinal Detachment
7%
Fluorescein Angiography
7%
Proliferative Diabetic Retinopathy
7%
Ranibizumab
7%
Aflibercept
7%
Fundus Photography
7%
Optical Coherence Tomography Angiography
7%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Diabetic Retinopathy
100%
Diabetic Macular Edema
23%
Vitreous Hemorrhage
15%
Clinical Trial
7%
Recurrent Disease
7%
Fluorescein
7%
Proliferative Diabetic Retinopathy
7%
Aflibercept
7%
Ranibizumab
7%
Retina Detachment
7%